Titre
Actualités sur le dépistage et la prévention des infections à VPH dans le cadre des cancers du col utérin [Current developments in uterine cervical carcinoma prevention and screening]
Type
synthèse (review)
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Mathevet, P.
Auteure/Auteur
Jacot-Guillarmod, M.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1660-9379
Statut éditorial
Publié
Date de publication
2015-10-28
Volume
11
Numéro
492
Première page
1999
Dernière page/numéro d’article
2003
Peer-reviewed
Oui
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
The causality between the HPV infection and the carcinoma of the uterine cervix is demonstrated. The benefits of the prophylactic HPV vaccine are emerging in the general population. This vaccine has no evident general side effect. So it is proposed for young women and young men. The commercialization of a nonavalent vaccine will increase its preventive activity. Already, international societies recommend using the HPV test for cervical carcinoma screening in replacement of the cytology in women more than 30-35 years old. In case of negative test, the interval between screenings can be increase until 5 years. In case of positive test, the cervical cytology is used for the triage, but other tests are under development. Due to the vaccine efficacy, the future modalities and the cost/benefits ratio of the screening should be questioned.
PID Serval
serval:BIB_EDA6F25440BD
PMID
Date de création
2017-11-15T14:34:03.888Z
Date de création dans IRIS
2025-05-21T00:58:45Z
Fichier(s)![Vignette d'image]()
En cours de chargement...
Nom
Rev Med Suis_2015_current developt in uterinepdf.pdf
Version du manuscrit
preprint
Taille
1.13 MB
Format
Adobe PDF
PID Serval
serval:BIB_EDA6F25440BD.P001
URN
urn:nbn:ch:serval-BIB_EDA6F25440BD0
Somme de contrôle
(MD5):e1ddad01833978eac8e432e6c4a90469